Spending on Glucagon-Like Peptide-1 Receptor Agonists Among US Adults
JAMA Network Open · 02.04.2025 · 8 (4) · e252964
DOI: 10.1001/jamanetworkopen.2025.2964 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 02.04.2025. Verfasst von Stavros Tsipas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Improving Health Outcomes, American Medical Association, Chicago, Illinois. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This economic evaluation estimates annual total US spending on glucagon-like peptide-1 receptor agonists from 2018 to 2023.
Autor:innen und Institutionen
- Improving Health Outcomes, American Medical Association, Chicago, Illinois.
- Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention, Atlanta.
Zitieren
APA
Tsipas, S., Khan, T., Loustalot, F., Myftari, K., & Wozniak, G. (2025). Spending on Glucagon-Like Peptide-1 Receptor Agonists Among US Adults. JAMA Network Open, 8(4), e252964. https://doi.org/10.1001/jamanetworkopen.2025.2964
Vancouver
Tsipas S, Khan T, Loustalot F, Myftari K, Wozniak G. Spending on Glucagon-Like Peptide-1 Receptor Agonists Among US Adults. JAMA Network Open. 2025;8(4):e252964. doi:10.1001/jamanetworkopen.2025.2964
BibTeX
@article{Tsipas2025,
author = {Tsipas, Stavros and Khan, Tamkeen and Loustalot, Fleetwood and Myftari, Klodiana and Wozniak, Gregory},
title = {Spending on Glucagon-Like Peptide-1 Receptor Agonists Among US Adults},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {4},
pages = {e252964},
doi = {10.1001/jamanetworkopen.2025.2964}
}
EUVIMED